Molecular Therapy and Targeted Treatment for Cancer (with Surgical Lenses)

Narjust Florez1, Arthi Sridhar2, Lauren Kiel3

  • 1Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA; Cancer Care Equity Program, Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.

Thoracic Surgery Clinics
|October 30, 2025
PubMed

Insights

This review covers targeted and combination therapies for early-stage lung cancer, emphasizing molecular testing and treatment strategies like neoadjuvant and adjuvant approaches.

Area of Science:

  • Oncology
  • Thoracic Surgery
  • Pharmacology

Background:

  • Early-stage, resectable lung cancer treatment is evolving.
  • Molecular testing is crucial for guiding therapy decisions.

Purpose of the Study:

  • To update on targeted and combination therapies for early-stage, resectable lung cancer.
  • To compare neoadjuvant and adjuvant treatment strategies.
  • To discuss future research directions.

Main Methods:

  • Review of landmark clinical trials.
  • Analysis of serious adverse events and surgical outcomes.
  • Discussion of contemporary developments in oncogenic drivers.

Main Results:

  • Highlighting clinical relevance of molecular testing.
  • Comparing immunotherapy and targeted therapy.
  • Overview of adverse events and surgical outcomes in trials.

Conclusions:

  • Targeted treatments show promise in the peri-operative setting.
  • Further research is needed for less common oncogenic drivers.
  • Balancing benefits and risks of neoadjuvant vs. adjuvant therapy is key.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.6K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.9K